1,4-Bis[2,7-dichloro-9-[(4-chlorophenyl)methylene]-9H-fluoren-4-yl]-3,6-dioxabicyclo[3.1.0]hexane

Details

Stereochemistry	RACEMIC
Molecular Formula	C43H27Cl5O2
Molecular Weight	752.938
Optical Activity	( + / - )
Defined Stereocenters	0 / 3
E/Z Centers	3
Charge	0

SHOW SMILES / InChI

Structure of 1,4-Bis[2,7-dichloro-9-[(4-chlorophenyl)methylene]-9H-fluoren-4-yl]-3,6-dioxabicyclo[3.1.0]hexane

Structure Search

SMILES

CC(=C/C=C)\C=C1\C2=CC(Cl)=CC=C2C3=C1C=C(Cl)C=C3C4OCC5(OC45)C6=C7C8=CC=C(Cl)C=C8\C(=C\C9=CC=C(Cl)C=C9)C7=CC(Cl)=C6

InChI

InChIKey=JHFSUXUESPEVFA-POHSERPPSA-N

InChI=1S/C43H27Cl5O2/c1-3-4-22(2)13-31-33-15-25(45)9-11-29(33)39-35(31)17-27(47)19-37(39)41-42-43(50-42,21-49-41)38-20-28(48)18-36-32(14-23-5-7-24(44)8-6-23)34-16-26(46)10-12-30(34)40(36)38/h3-20,41-42H,1,21H2,2H3/b22-4+,31-13-,32-14-

HIDE SMILES / InChI

Molecular Formula	C43H27Cl5O2
Molecular Weight	752.938
Charge	0
Count

Stereochemistry	MIXED
Additional Stereochemistry	No
Defined Stereocenters	0 / 3
E/Z Centers	3
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Mon Mar 31 23:42:07 GMT 2025` Edited by `admin` on `Mon Mar 31 23:42:07 GMT 2025`
Record UNII	756N9TVN3S
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

LUMEFANTRINE IMPURITY B [WHO-IP]

Preferred Name

English

1,4-Bis[2,7-dichloro-9-[(4-chlorophenyl)methylene]-9H-fluoren-4-yl]-3,6-dioxabicyclo[3.1.0]hexane

Systematic Name

English

Code System Code Type Description

CAS

1795129-61-1

Created by admin on Mon Mar 31 23:42:07 GMT 2025 , Edited by admin on Mon Mar 31 23:42:07 GMT 2025

PRIMARY

FDA UNII

756N9TVN3S

Created by admin on Mon Mar 31 23:42:07 GMT 2025 , Edited by admin on Mon Mar 31 23:42:07 GMT 2025

PRIMARY

Related Record Type Details


					F38R0JR742

LUMEFANTRINE

PARENT -> IMPURITY

Comments:

The impurity peaks are eluted at the following relative retention with reference to lumefantrine (retention time about 10 minutes): impurity B about 4.3. The test is not valid unless the peak-to-valley ratio (Hp/Hv) is at least 2.0, where Hp = height above the baseline of the peak due to impurity A and Hv = the height above the baseline of the lowest point of the curve separating this peak from that due to lumefantrine.

Amount: